Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Weight loss jabs could reduce the risk of up to 14 types of cancer, new research has found. Mounjaro, Ozempic and other ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

Mounjaro, Ozempic and other fat-melting injections have ushered in a new era in the war on obesity, but have also been linked to other benefits, such as slashing heart attack risk.

By Nancy Lapid (Reuters) -Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the ...

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Ozempic users were found to have a reduced risk of cognitive deficit compared ... AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its ...

Ozempic use can potentially cause issues including thyroid cancer, pancreatitis ... "It was just a waste of money and time." Given the risk of side effects, Emini-Sadiku said Ozempic was "by ...